(R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate, 98.0%, 1mg

dihydro-3(2H)-thiophenone 1,1-dioxide, 95.0%, 2.5g

5-Ethoxy-2-fluoro-4-iodopyridine, 95%, 250mg

1/? first red plate 530 nm in slide for incident illumination of iScope models for polarization

(E)-4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane, 95+%, 100mg

Ethyl 3h-imidazo[4,5-c]pyridine-2-carboxylate, 98%, 1g

2-Bromo-5-chloro-3-methylpyridine, 98.0%, 10g

(1S,4S)-5-tert-Butoxycarbonyl-2-oxa-5-azabicyclo[2.2.1]heptane-1-carboxylic acid, 98%, 250mg

4-Bromo-2-phenyloxazole, 95.0%, 100mg

3-(4-Chloro-2-methylphenyl)-2-methyl-1-propene, 97.0%, 2g

2-Bromo-4-chloroaniline, 98.0%, 10g

1-Butyl-3-phenylthiourea, 1g

5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one, 97%, 1g